Atlas Trials

Mesenchymal Stromal Cells for the Treatment of Patients With COVID-19.

Clinical trial NCT05433298 · WITHDRAWN

Trial details

NCT number
NCT05433298
Sponsor
Paulo Brofman
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
COVID-19 PneumoniaCOVID-19
Start date
2022-05-01
Primary completion
2022-11-26
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.